Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2024-05-24 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by T. Rowe Price Group, Inc. and its subsidiaries, crossing specific percentage thresholds (e.g., 9.99% and 10.15%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2024-05-24 English
Evotec reports Q1 2024 results and provides corporate update
Earnings Release Classification · 1% confidence The document explicitly states it reports 'Q1 2024 results' and provides 'financial results and corporate updates for the first quarter 2024'. It includes detailed financial tables for the 'First three months of 2024' and discusses key performance indicators, segment revenues, and Adjusted EBITDA for this period. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. Therefore, the classification is Interim / Quarterly Report (IR). The document is substantial (over 21,000 characters) and contains the full results, not just an announcement of publication, ruling out RPA/RNS based on the 'MENU VS MEAL' rule. Q1 2024
2024-05-22 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a legal entity (T. Rowe Price Group, Inc.) in Evotec SE, referencing specific German securities laws (WpHG Sections 33, 34, 38, 40). This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds. Although the header mentions 'Voting Rights Announcements', the content structure is a standard major holding disclosure.
2024-05-21 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting the 'Notification of Major Holdings' by a shareholder (Franklin Templeton Institutional, LLC) in Evotec SE, specifying the percentage of voting rights acquired/disposed of on a specific date (May 14, 2024). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The filing code for Major Shareholding Notification is MRQ.
2024-05-16 English
Evotec SE to announce results for first quarter 2024 on 22 may 2024
Report Publication Announcement Classification · 1% confidence The document is a short corporate news release dated May 15, 2024, announcing that Evotec SE will release its financial results for the first quarter of 2024 on May 22, 2024. It provides details for an upcoming conference call/webcast to discuss these results. Since this document is an announcement *about* the future release of financial results, rather than the results themselves (which would likely be an ER or IR), it fits the definition of a Report Publication Announcement (RPA). It is not the full earnings release (ER) or the comprehensive interim report (IR), but rather the notice of when those reports will be discussed.
2024-05-15 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instruments held by a major shareholder (The Goldman Sachs Group, Inc.) in Evotec SE, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. Although the header mentions 'Voting Rights Announcements', the content structure aligns perfectly with the 'Major Shareholding Notification' category (MRQ) as it details the crossing of voting rights thresholds by an external entity.
2024-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.